TipRanksTop Financial ExpertsInsidersSmith Kevin Raymond Merrill

Smith Kevin Raymond Merrill Insider Profile

4 Followers
Smith Kevin Raymond Merrill, Director at OncoSec Medical, holds ― shares in OncoSec Medical (Ticker: ONCSQ), holds 70.27K shares in Inogen (Ticker: INGN). Most recently, Smith Kevin Raymond Merrill ― shares of OncoSec Medical on ― for an estimated value of ―.
tipranks
Smith Kevin Raymond Merrill

Smith Kevin Raymond Merrill
OncoSec Medical (ONCSQ)
Director

Not Ranked
Smith Kevin Raymond Merrill has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$545K
100.00%
0.00%
A breakdown of Smith Kevin Raymond Merrill's holdings

Insider Roles

Inogen
(INGN)
CEO & President, Director
OncoSec Medical
(ONCSQ)
Director
Roles that Smith Kevin Raymond Merrill holds in companies

Most Profitable Insider Trade

Stock:
Inogen
(INGN)
Rating:Informative Buy
Date:Mar 04, 2025 - Today
Return:-3.30%
The most profitable trade made by Smith Kevin Raymond Merrill

Smith Kevin Raymond Merrill's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
OncoSec Medical
Director
Inogen
Mar 04, 2025
CEO & President, Director
Uninformative Buy
366.61K
$545.33K
List of latest transactions for each holding click on a transaction to see Smith Kevin Raymond Merrill's performance on stock

Smith Kevin Raymond Merrill insider profile FAQ

What is the percentage of profitable transactions made by Smith Kevin Raymond Merrill?
The percentage of profitable transactions made by Smith Kevin Raymond Merrill is ―.
    What is the average return per transaction made by Smith Kevin Raymond Merrill?
    The average return per transaction made by Smith Kevin Raymond Merrill is ―.
      What stocks does Smith Kevin Raymond Merrill hold?
      Smith Kevin Raymond Merrill holds: ONCSQ, INGN stocks.
        What was Smith Kevin Raymond Merrill’s latest transaction?
        Smith Kevin Raymond Merrill latest transaction was an Uninformative Buy of ―.
          What was Smith Kevin Raymond Merrill's most profitable transaction?
          Smith Kevin Raymond Merrill’s most profitable transaction was an Informative Buy of INGN stock on March 4, 2025. The return on the trade was -3.30%.
            What is Smith Kevin Raymond Merrill's role in OncoSec Medical?
            Smith Kevin Raymond Merrill's role in OncoSec Medical is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.